306 related articles for article (PubMed ID: 26741961)
1. Differentiating Radiation-Induced Necrosis from Recurrent Brain Tumor Using MR Perfusion and Spectroscopy: A Meta-Analysis.
Chuang MT; Liu YS; Tsai YS; Chen YC; Wang CK
PLoS One; 2016; 11(1):e0141438. PubMed ID: 26741961
[TBL] [Abstract][Full Text] [Related]
2. MR spectroscopy using normalized and non-normalized metabolite ratios for differentiating recurrent brain tumor from radiation injury.
Elias AE; Carlos RC; Smith EA; Frechtling D; George B; Maly P; Sundgren PC
Acad Radiol; 2011 Sep; 18(9):1101-8. PubMed ID: 21820634
[TBL] [Abstract][Full Text] [Related]
3. Differentiation between brain tumor recurrence and radiation injury using MR spectroscopy.
Weybright P; Sundgren PC; Maly P; Hassan DG; Nan B; Rohrer S; Junck L
AJR Am J Roentgenol; 2005 Dec; 185(6):1471-6. PubMed ID: 16304000
[TBL] [Abstract][Full Text] [Related]
4. Distinction between recurrent glioma and radiation injury using magnetic resonance spectroscopy in combination with diffusion-weighted imaging.
Zeng QS; Li CF; Liu H; Zhen JH; Feng DC
Int J Radiat Oncol Biol Phys; 2007 May; 68(1):151-8. PubMed ID: 17289287
[TBL] [Abstract][Full Text] [Related]
5. Differentiation between intra-axial metastatic tumor progression and radiation injury following fractionated radiation therapy or stereotactic radiosurgery using MR spectroscopy, perfusion MR imaging or volume progression modeling.
Huang J; Wang AM; Shetty A; Maitz AH; Yan D; Doyle D; Richey K; Park S; Pieper DR; Chen PY; Grills IS
Magn Reson Imaging; 2011 Sep; 29(7):993-1001. PubMed ID: 21571478
[TBL] [Abstract][Full Text] [Related]
6. Brain magnetic resonance spectroscopy to differentiate recurrent neoplasm from radiation necrosis: A systematic review and meta-analysis.
Aseel A; McCarthy P; Mohammed A
J Neuroimaging; 2023 Mar; 33(2):189-201. PubMed ID: 36631883
[TBL] [Abstract][Full Text] [Related]
7. Differentiation between brain tumor recurrence and radiation injury using perfusion, diffusion-weighted imaging and MR spectroscopy.
Bobek-Billewicz B; Stasik-Pres G; Majchrzak H; Zarudzki L
Folia Neuropathol; 2010; 48(2):81-92. PubMed ID: 20602289
[TBL] [Abstract][Full Text] [Related]
8. Recurrent glioblastoma multiforme versus radiation injury: a multiparametric 3-T MR approach.
Di Costanzo A; Scarabino T; Trojsi F; Popolizio T; Bonavita S; de Cristofaro M; Conforti R; Cristofano A; Colonnese C; Salvolini U; Tedeschi G
Radiol Med; 2014 Aug; 119(8):616-24. PubMed ID: 24408041
[TBL] [Abstract][Full Text] [Related]
9. Multivoxel 3D proton MR spectroscopy in the distinction of recurrent glioma from radiation injury.
Zeng QS; Li CF; Zhang K; Liu H; Kang XS; Zhen JH
J Neurooncol; 2007 Aug; 84(1):63-9. PubMed ID: 17619225
[TBL] [Abstract][Full Text] [Related]
10. Distinction between glioma progression and post-radiation change by combined physiologic MR imaging.
Matsusue E; Fink JR; Rockhill JK; Ogawa T; Maravilla KR
Neuroradiology; 2010 Apr; 52(4):297-306. PubMed ID: 19834699
[TBL] [Abstract][Full Text] [Related]
11. Role of magnetic resonance spectroscopy for the differentiation of recurrent glioma from radiation necrosis: a systematic review and meta-analysis.
Zhang H; Ma L; Wang Q; Zheng X; Wu C; Xu BN
Eur J Radiol; 2014 Dec; 83(12):2181-2189. PubMed ID: 25452098
[TBL] [Abstract][Full Text] [Related]
12. [Usefulness of quantitative H-MR spectroscopy for the differentiation between radiation necrosis and recurrence of anaplastic oligodendroglioma].
Isobe T; Akutsu H; Yamamoto T; Shiigai M; Masumoto T; Nakai K; Takano S; Anno I; Matsumura A
No Shinkei Geka; 2011 May; 39(5):485-90. PubMed ID: 21512199
[TBL] [Abstract][Full Text] [Related]
13. [Application of (1)H MR spectroscopic imaging in radiation oncology: choline as a marker for determining the relative probability of tumor progression after radiation of glial brain tumors].
Lichy MP; Bachert P; Hamprecht F; Weber MA; Debus J; Schulz-Ertner D; Schlemmer HP; Kauczor HU
Rofo; 2006 Jun; 178(6):627-33. PubMed ID: 16703499
[TBL] [Abstract][Full Text] [Related]
14. Contrast-Enhanced Perfusion MR Imaging to Differentiate Between Recurrent/Residual Brain Neoplasms and Radiation Necrosis.
Metaweh NAK; Azab AO; El Basmy AAH; Mashhour KN; El Mahdy WM
Asian Pac J Cancer Prev; 2018 Apr; 19(4):941-948. PubMed ID: 29693348
[TBL] [Abstract][Full Text] [Related]
15. Value of DWI Combined with Magnetic Resonance Spectroscopy in the Differential Diagnosis between Recurrent Glioma and Radiation Injury: A Meta-Analysis.
Li H; Duan Y; Liu N; Dong J; Liang Y; Ju R
Int J Clin Pract; 2022; 2022():1629570. PubMed ID: 36380750
[TBL] [Abstract][Full Text] [Related]
16. Posttherapeutic intraaxial brain tumor: the value of perfusion-sensitive contrast-enhanced MR imaging for differentiating tumor recurrence from nonneoplastic contrast-enhancing tissue.
Sugahara T; Korogi Y; Tomiguchi S; Shigematsu Y; Ikushima I; Kira T; Liang L; Ushio Y; Takahashi M
AJNR Am J Neuroradiol; 2000 May; 21(5):901-9. PubMed ID: 10815666
[TBL] [Abstract][Full Text] [Related]
17. Developing a clinical decision model: MR spectroscopy to differentiate between recurrent tumor and radiation change in patients with new contrast-enhancing lesions.
Smith EA; Carlos RC; Junck LR; Tsien CI; Elias A; Sundgren PC
AJR Am J Roentgenol; 2009 Feb; 192(2):W45-52. PubMed ID: 19155380
[TBL] [Abstract][Full Text] [Related]
18. Multimodal MRI in the characterization of glial neoplasms: the combined role of single-voxel MR spectroscopy, diffusion imaging and echo-planar perfusion imaging.
Zonari P; Baraldi P; Crisi G
Neuroradiology; 2007 Oct; 49(10):795-803. PubMed ID: 17619871
[TBL] [Abstract][Full Text] [Related]
19. Associations among magnetic resonance spectroscopy, apparent diffusion coefficients, and image-guided histopathology with special attention to radiation necrosis.
Rock JP; Scarpace L; Hearshen D; Gutierrez J; Fisher JL; Rosenblum M; Mikkelsen T
Neurosurgery; 2004 May; 54(5):1111-7; discussion 1117-9. PubMed ID: 15113465
[TBL] [Abstract][Full Text] [Related]
20. Proton MR spectroscopy of delayed cerebral radiation in monkeys and humans after brachytherapy.
Kinoshita K; Tada E; Matsumoto K; Asari S; Ohmoto T; Itoh T
AJNR Am J Neuroradiol; 1997 Oct; 18(9):1753-61. PubMed ID: 9367328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
